- impaired macrophage phagocytosis / MGI
- decreased inflammatory response / MGI
- increased susceptibility to bacterial infection / MGI
- abnormal cell-mediated immunity / MGI
- abnormal macrophage physiology / MGI
- abnormal macrophage antigen presentation / MGI
- abnormal dendritic cell antigen presentation / MGI
- increased IgG level / MGI
- abnormal type I hypersensitivity reaction / MGI
- decreased susceptibility to induced arthritis / MGI
- decreased susceptibility to autoimmune hemolytic anemia / MGI
- abnormal dendritic cell differentiation / MGI
C.129P2-Fcgr1tm1Jsv/Cnrm
Status | Available to order |
EMMA ID | EM:01744 |
Citation information | RRID:IMSR_EM:01744 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C.129P2-Fcgr1tm1Jsv/Cnrm |
Alternative name | CD64 (Balb/C) 376 |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Fcgr1tm1Jsv |
Gene/Transgene symbol | Fcgr1 |
Information from provider
Provider | Verbeek J.S. Verbeek J.S. |
Provider affiliation | Leiden University Medical Center |
Genetic information | Deletion of 3'-part of promoter, exon 1 (L1 domain), exon 2 (L2 domain) and 5'-part of exon 3 (ligand binding EC1 domain), replaced by a PGK-hygromycin resistance cassette. |
Phenotypic information | Impaired IgG2a (and IgG2b) antibody effector pathways. |
References |
|
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
MGI phenotypes (gene matching)
Literature references
- FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.;Ioan-Facsinay A, de Kimpe S J, Hellwig S M M, van Lent P L, Hofhuis F M A, van Ojik H H, Sedlik C, da Silveira S A, Gerber J, de Jong Y F, Roozendaal R, Aarden L A, van den Berg W B, Saito T, Mosser D, Amigorena S, Izui S, van Ommen G J B, van Vugt M, van de Winkel J G J, Verbeek J S, ;2002;Immunity;16;391-402; 11911824
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).